Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ono Pharmaceutical Co. (OPHLF : OTC)

• Company Description    Ono Pharmaceuticals produces, purchases and sells pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals. Number of Employees: 4,287

• Price / Volume Information    Yesterday's Closing Price: $15.00 Daily Weekly Monthly 20 Day Moving Average: 546 shares Shares Outstanding: 469.91 (millions) Market Capitalization: $7,048.62 (millions) Beta: 0.33 52 Week High: $18.67 52 Week Low: $10.27 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.97% 3.86% 12 Week 3.09% 0.99% Year To Date 16.55% 5.10%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8-2 Kyutaromachi 1-chome Chuo-ku - Osaka,M0 541-8564 JPN ph: 816-6263-5670 fax: 816-6263-2950 None http://www.ono-pharma.com

• General Corporate Information    Officers Akira Sagara - Chief Executive Officer; Chairman and Director Takino Toichi - Chief Operating Officer; President and Director Akihiro Tsujinaka - Executive Vice President and Director Masao Nomura - Director Akiko Okuno - Director Peer Information Ono Pharmaceutical Co. (GSAC) Ono Pharmaceutical Co. (CASIF) Ono Pharmaceutical Co. (ALCD.) Ono Pharmaceutical Co. (OMNN) Ono Pharmaceutical Co. (CGPI.) Ono Pharmaceutical Co. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: J61546115 SIC: 2834 Fiscal Year Fiscal Year End: March Last Reported Quarter: 06/01/26 Next Expected EPS Date: 10/29/26 Share - Related Items Shares Outstanding: 469.91 Most Recent Split Date: 3.00 (5.00:1) Beta: 0.33 Market Capitalization: $7,048.62 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.26 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $1.00 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 10/29/26

• Fundamental Ratios P/E Current FY Estimate: 15.00 Trailing 12 Months: 13.27 PEG Ratio: - Price Ratios Price/Book: 1.28 Price/Cash Flow: 10.08 Price / Sales: 2.13 EPS Growth vs. Year Ago Period: 53.85% vs. Previous Quarter: 3,900.00% Sales Growth vs. Year Ago Period: -17.43% vs. Previous Quarter: -7.60% ROE 06/30/26 - 9.77 03/31/26 - 8.59 12/31/25 - 7.76 ROA 06/30/26 - 7.63 03/31/26 - 6.62 12/31/25 - 5.91 Current Ratio 06/30/26 - 3.28 03/31/26 - 2.86 12/31/25 - 3.02 Quick Ratio 06/30/26 - 2.86 03/31/26 - 2.51 12/31/25 - 2.56 Operating Margin 06/30/26 - 16.16 03/31/26 - 13.51 12/31/25 - 12.29 Net Margin 06/30/26 - 15.02 03/31/26 - 13.51 12/31/25 - 12.29 Pre-Tax Margin 06/30/26 - - 03/31/26 - 17.96 12/31/25 - - Book Value 06/30/26 - 11.70 03/31/26 - 11.39 12/31/25 - 11.69 Inventory Turnover 06/30/26 - - 03/31/26 - 2.03 12/31/25 - - Debt-to-Equity 06/30/26 - 0.08 03/31/26 - 0.09 12/31/25 - 0.10 Debt-to-Capital 06/30/26 - 7.18 03/31/26 - 8.05 12/31/25 - 8.89

Powered by Zacks Investment Research ©